DK1638591T3 - Klasse iii slrp-agonister til reduktion af blodkardannelse - Google Patents

Klasse iii slrp-agonister til reduktion af blodkardannelse

Info

Publication number
DK1638591T3
DK1638591T3 DK04735259.6T DK04735259T DK1638591T3 DK 1638591 T3 DK1638591 T3 DK 1638591T3 DK 04735259 T DK04735259 T DK 04735259T DK 1638591 T3 DK1638591 T3 DK 1638591T3
Authority
DK
Denmark
Prior art keywords
agonists
reducing blood
class iii
blood card
card formation
Prior art date
Application number
DK04735259.6T
Other languages
English (en)
Inventor
Paul N Faculty Of Medicine Bishop
Original Assignee
Univ Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0312292A external-priority patent/GB0312292D0/en
Priority claimed from GB0400547A external-priority patent/GB0400547D0/en
Application filed by Univ Manchester filed Critical Univ Manchester
Application granted granted Critical
Publication of DK1638591T3 publication Critical patent/DK1638591T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK04735259.6T 2003-05-29 2004-05-28 Klasse iii slrp-agonister til reduktion af blodkardannelse DK1638591T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0312292A GB0312292D0 (en) 2003-05-29 2003-05-29 Treatment of blood vessels
GB0400547A GB0400547D0 (en) 2004-01-12 2004-01-12 Treatment of blood vessels
PCT/GB2004/002269 WO2004105784A1 (en) 2003-05-29 2004-05-28 Class iii slrp agonists for the reduction of blood vessel formation

Publications (1)

Publication Number Publication Date
DK1638591T3 true DK1638591T3 (da) 2013-06-03

Family

ID=33492244

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04735259.6T DK1638591T3 (da) 2003-05-29 2004-05-28 Klasse iii slrp-agonister til reduktion af blodkardannelse

Country Status (8)

Country Link
US (2) US7358224B2 (da)
EP (1) EP1638591B1 (da)
JP (1) JP4808623B2 (da)
DK (1) DK1638591T3 (da)
ES (1) ES2408656T3 (da)
PL (1) PL1638591T3 (da)
PT (1) PT1638591E (da)
WO (1) WO2004105784A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1638591E (pt) * 2003-05-29 2013-05-22 Univ Manchester Agonistas de slrp de classe iii para a redução da formação de vasos sanguíneos
GB0423273D0 (en) * 2004-10-20 2004-11-24 Univ Manchester Treatment of cancer
GB0724832D0 (en) * 2007-12-20 2008-01-30 Univ Manchester Proteins and nucleic acids
JP5592487B2 (ja) 2009-07-27 2014-09-17 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 心不全の評価におけるミメカンの使用
EA201290442A1 (ru) * 2009-12-04 2012-11-30 Юклид Системз Корпорэйшн Композиция и способы профилактики и лечения макулярной дегенерации, диабетической ретинопатии и диабетического макулярного отека
CN102188694B (zh) * 2010-03-11 2015-05-06 上海交通大学医学院附属瑞金医院 骨生成诱导因子的用途
EP3115784A1 (en) * 2015-07-10 2017-01-11 Koss, Michael Janusz Polypeptide marker for analysis, diagnosis and therapy of eye-related diseases
WO2017083925A1 (en) * 2015-11-19 2017-05-26 Garvan Institute Of Medical Research Compounds and methods for treating metabolic disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827702A (en) * 1994-10-31 1998-10-27 Genentech, Inc. Ocular gene therapy
DE4445630A1 (de) 1994-12-21 1996-06-27 Forssmann Wolf Georg Humane zirkulierende Peptidfragmente 20-92 und 23-74 des Precursor des Osteoinduktiven Faktors kurz: OIF-20-92 und OIF 23-74
NZ320006A (en) 1995-10-23 2001-12-21 Meditech Res Ltd An adjuvant composition comprising hyaluronic acid for gene therapy either in the sense or antisense direction
EP0928203B1 (en) * 1996-09-24 2006-10-25 Merck & Co., Inc. Compounds for the inhibition of angiogenesis by gene therapy
WO1998024466A1 (en) 1996-12-05 1998-06-11 Alcon Laboratories, Inc. THE USE OF INHIBITORS OF TGF-β'S FUNCTIONS TO AMELIORATE OCULAR PATHOLOGY
WO2000068264A2 (en) 1999-05-10 2000-11-16 The Texas A & M University System A peptide inhibitor of fibrinogen blood clotting
DE60043736D1 (de) 1999-09-15 2010-03-11 Euclid Systems Corp Zusammensetzung zur stabilisierung des corneagewebon kontaktlinsen
JP2003511012A (ja) * 1999-09-24 2003-03-25 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド ３２個のヒト分泌タンパク質
US7304137B2 (en) * 2001-12-13 2007-12-04 The Texas A & M University System Nucleotide and amino acid sequences of asporins
PT1638591E (pt) 2003-05-29 2013-05-22 Univ Manchester Agonistas de slrp de classe iii para a redução da formação de vasos sanguíneos
GB0423273D0 (en) 2004-10-20 2004-11-24 Univ Manchester Treatment of cancer

Also Published As

Publication number Publication date
US7910567B2 (en) 2011-03-22
JP4808623B2 (ja) 2011-11-02
PL1638591T3 (pl) 2013-10-31
WO2004105784A1 (en) 2004-12-09
ES2408656T3 (es) 2013-06-21
EP1638591A1 (en) 2006-03-29
EP1638591B1 (en) 2013-03-13
US20070021334A1 (en) 2007-01-25
PT1638591E (pt) 2013-05-22
JP2007502855A (ja) 2007-02-15
US7358224B2 (en) 2008-04-15
US20090130192A1 (en) 2009-05-21

Similar Documents

Publication Publication Date Title
NO20034321D0 (no) Fremgangsmåte for identifisering
LU92427I2 (fr) Aripiprazole
DK1575416T3 (da) Fremgangsmåder til diagnosticering af præeklampsi
DE602004006169D1 (de) Substituierte 8'-pyri(mi)dinyl-dihydrospiro-äcycloalkylaminü-pyrimidoä1,2aüpyrimidin-6-onderivate
DE602004018654D1 (de) Se
DE502004003292D1 (de) Flugzeug
DE60318511D1 (de) Gleitelement
NL1027608A1 (nl) Automatisch uitlijnend scintillator-collimatorsamenstel.
DE60325447D1 (de) Gleitelement
DE602004031845D1 (de) Ng
DE60308579D1 (de) Gleitelement
NO2015005I2 (no) Flutemetamol (18F)
DE602004007640D1 (de) Kartenverbinder
DE60331481D1 (de) Ic-karte
IS8015A (is) 6-útskipt imídasópýrasín
DK1638591T3 (da) Klasse iii slrp-agonister til reduktion af blodkardannelse
DE502004005180D1 (de) Stereomikroskop
DE602004001960D1 (de) Autofokussystem
DE602004018799D1 (de) Ng
DE602004022063D1 (de) Mehrzweckschlitten
DE502004008448D1 (de) Chipkarte
DE602004023341D1 (de) Chronograph
DE602004008997D1 (de) Kartensteckverbinder
DE10394265D2 (de) Gleitelement
ATE394370T1 (de) Von vitamin d abgeleitete monohalogenvinylverbindungen